List of Tables
    Table 1. Tumor Necrosis Factor Receptor Superfamily Member 4 CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Tumor Necrosis Factor Receptor Superfamily Member 4 Market Trends
    Table 3. Tumor Necrosis Factor Receptor Superfamily Member 4 Market Drivers
    Table 4. Tumor Necrosis Factor Receptor Superfamily Member 4 Market Challenges
    Table 5. Tumor Necrosis Factor Receptor Superfamily Member 4 Market Restraints
    Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Tumor Necrosis Factor Receptor Superfamily Member 4 Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Share by Manufacturer, 2017-2022
    Table 15. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 4 as of 2021)
    Table 18. Top Players of Tumor Necrosis Factor Receptor Superfamily Member 4 in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 4 Product Type
    Table 20. Date of International Manufacturers Enter into Tumor Necrosis Factor Receptor Superfamily Member 4 Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Tumor Necrosis Factor Receptor Superfamily Member 4 Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Abeome Corp Corporation Information
    Table 43. Abeome Corp Description and Business Overview
    Table 44. Abeome Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Abeome Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Product
    Table 46. Abeome Corp Recent Development
    Table 47. Alligator Bioscience AB Corporation Information
    Table 48. Alligator Bioscience AB Description and Business Overview
    Table 49. Alligator Bioscience AB Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Alligator Bioscience AB Product
    Table 51. Alligator Bioscience AB Recent Development
    Table 52. Apogenix GmbH Corporation Information
    Table 53. Apogenix GmbH Description and Business Overview
    Table 54. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Apogenix GmbH Product
    Table 56. Apogenix GmbH Recent Development
    Table 57. BioInvent International AB Corporation Information
    Table 58. BioInvent International AB Description and Business Overview
    Table 59. BioInvent International AB Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. BioInvent International AB Product
    Table 61. BioInvent International AB Recent Development
    Table 62. Bristol-Myers Squibb Company Corporation Information
    Table 63. Bristol-Myers Squibb Company Description and Business Overview
    Table 64. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Bristol-Myers Squibb Company Product
    Table 66. Bristol-Myers Squibb Company Recent Development
    Table 67. Denceptor Therapeutics Ltd Corporation Information
    Table 68. Denceptor Therapeutics Ltd Description and Business Overview
    Table 69. Denceptor Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Denceptor Therapeutics Ltd Product
    Table 71. Denceptor Therapeutics Ltd Recent Development
    Table 72. Enumeral Biomedical Holdings Inc Corporation Information
    Table 73. Enumeral Biomedical Holdings Inc Description and Business Overview
    Table 74. Enumeral Biomedical Holdings Inc Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Enumeral Biomedical Holdings Inc Product
    Table 76. Enumeral Biomedical Holdings Inc Recent Development
    Table 77. GlaxoSmithKline Plc Corporation Information
    Table 78. GlaxoSmithKline Plc Description and Business Overview
    Table 79. GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. GlaxoSmithKline Plc Product
    Table 81. GlaxoSmithKline Plc Recent Development
    Table 82. Glenmark Pharmaceuticals Ltd Corporation Information
    Table 83. Glenmark Pharmaceuticals Ltd Description and Business Overview
    Table 84. Glenmark Pharmaceuticals Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Glenmark Pharmaceuticals Ltd Product
    Table 86. Glenmark Pharmaceuticals Ltd Recent Development
    Table 87. Incyte Corp Corporation Information
    Table 88. Incyte Corp Description and Business Overview
    Table 89. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Incyte Corp Product
    Table 91. Incyte Corp Recent Development
    Table 92. Kyowa Hakko Kirin Co Ltd Corporation Information
    Table 93. Kyowa Hakko Kirin Co Ltd Description and Business Overview
    Table 94. Kyowa Hakko Kirin Co Ltd Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Kyowa Hakko Kirin Co Ltd Product
    Table 96. Kyowa Hakko Kirin Co Ltd Recent Development
    Table 97. MedImmune LLC Corporation Information
    Table 98. MedImmune LLC Description and Business Overview
    Table 99. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. MedImmune LLC Product
    Table 101. MedImmune LLC Recent Development
    Table 102. Pfizer Inc Corporation Information
    Table 103. Pfizer Inc Description and Business Overview
    Table 104. Pfizer Inc Tumor Necrosis Factor Receptor Superfamily Member 4 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Pfizer Inc Product
    Table 106. Pfizer Inc Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Tumor Necrosis Factor Receptor Superfamily Member 4 Customers List
    Table 110. Tumor Necrosis Factor Receptor Superfamily Member 4 Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 4 Product Picture
    Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Size 2017-2028 (US$ Million)
    Figure 4. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales 2017-2028 (K Units)
    Figure 5. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Market Size 2017-2028 (US$ Million)
    Figure 7. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales 2017-2028 (K Units)
    Figure 8. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Tumor Necrosis Factor Receptor Superfamily Member 4 Report Years Considered
    Figure 11. Product Picture of ATOR-1015
    Figure 12. Product Picture of ENUM-004
    Figure 13. Product Picture of GBR-8383
    Figure 14. Product Picture of GSK-3174998
    Figure 15. Product Picture of Others
    Figure 16. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Share by Type in 2022 & 2028
    Figure 17. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Type (2017-2028) & (K Units)
    Figure 20. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price by Type (2017-2028) & (USD/Unit)
    Figure 22. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Market Share by Type in 2022 & 2028
    Figure 23. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Type (2017-2028) & (K Units)
    Figure 26. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Price by Type (2017-2028) & (USD/Unit)
    Figure 28. Product Picture of Oocology
    Figure 29. Product Picture of Immunology
    Figure 30. Product Picture of Dermatology
    Figure 31. Product Picture of Gastrointestinal
    Figure 32. Product Picture of Others
    Figure 33. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Share by Application in 2022 & 2028
    Figure 34. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Application (2017-2028) & (K Units)
    Figure 37. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Tumor Necrosis Factor Receptor Superfamily Member 4 Price by Application (2017-2028) & (USD/Unit)
    Figure 39. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Market Share by Application in 2022 & 2028
    Figure 40. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales by Application (2017-2028) & (K Units)
    Figure 43. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Tumor Necrosis Factor Receptor Superfamily Member 4 Price by Application (2017-2028) & (USD/Unit)
    Figure 45. North America Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. North America Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 50. Europe Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 57. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Latin America Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 74. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Tumor Necrosis Factor Receptor Superfamily Member 4 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Tumor Necrosis Factor Receptor Superfamily Member 4 Value Chain
    Figure 79. Tumor Necrosis Factor Receptor Superfamily Member 4 Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed